In this model, not only arthralgia but also early cortical bone loss, reported to be significantly increased in ACPA-positive pre-RA patients (226), could be the result of the interaction of ACPAs with key bone constituents. This evidence concerns the gene PRTN3 and rheumatoid arthritis.